Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jean Franchi, Paul Ethridge, Laura Sullivan, and more


Good Start Genetics has expanded its senior management team.

Jean Franchi will serve as chief financial officer. Previously, she held a variety of senior positions at Genzyme (now part of Sanofi), including as senior vice president of corporate finance.

Paul Ethridge will be the company's vice president of human resources. He spent the last 20 years at GlaxoSmithKline, most recently as global vice president of human resources for its consumer healthcare supply division.

Laura Sullivan will be vice president of customer care and reimbursement. She previously served as vice president of reimbursement and contracting at Genzyme Genetics (now part of Laboratory Corporation of America).

Good Start has also promoted Gregory Porreca, a founder of the company, to vice president of research and technology, and Stephanie Hallam to vice president of laboratory operations and medical director.

Knome has expanded its management team, hiring Chuck Abdalian as chief financial officer, Adam Rosenberg as senior vice president and head of corporate development, and Jay Therrien as senior vice president and head of global sales.

Abdalian most recently served as senior vice president of finance and chief financial officer of Molecular Insight Pharmaceuticals. He also served as senior vice president of finance and chief financial officer at Coley Pharmaceutical Group, CEO of Pelias Technologies, and chief financial officer of Emisphere Technologies. He holds a BS from Norwich University and an MBA from the Wharton School at the University of Pennsylvania.

Rosenberg, prior to joining Knome, advised emerging companies as a director and consultant and also co-founded the start-up Clean Membranes. He has also served as CEO of Link Medicine and helped launch the law firm Faber Daeufer & Rosenberg PC. He holds a BA from Whittier College and a JD from University of Virginia School of Law.

Thierrien was previously vice president of commercial operations and sequencing at Life Technologies. He has also held various positions at Illumina, including director of sales for Asia Pacific and Japan. He holds a BS from the University of Illinois at Urbana-Champaign and a PhD from the University of Kansas.

Knome has also appointed Hugh Reinhoff to its scientific advisory board. Reinhoff is currently a managing director of Life Science Venture Partners, an adjunct scientist at the Children's Hospital Oakland Research Institute, and CEO of FerroKin BioSciences.

Reinhoff founded the nonprofit, and previously served as CEO and chairman of the board at DNA Sciences. He was also founding director of Healtheon, now known as WebMD Health. He holds an MD from the Johns Hopkins University School of Medicine.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.